Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NiliMedix Ltd.

www.nilimedix.com

Latest From NiliMedix Ltd.

Diabetes Device Market: Innovation Highlights Road to Growth

Despite the slumping economy, the diabetes market continues to be a very active area, with treatment-changing products recently launched or in late-stage development. Although no industry has been able to escape the effects of the US recession, and certain segments of the diabetes market have seen a decline in sales, other areas continue to move forward. Once the economy returns to healthier levels, the overall market is expected to see a renewal of growth. Meanwhile, an expanded emphasis on emerging international markets could help offset some of the sluggish numbers in the US and parts of Europe.
Medical Device

Insulin Device Companies' New Mantra: Real Simple

Companies developing devices for diabetes have to ask a question that companies in other medical device fields don't: what about the users, the people with diabetes? How will they use the device? Because in diabetes care, management of the disease is left up to the patient, who is asked to self-test blood glucose levels, self-administer insulin by injection, and pay attention to diet and exercise. Acknowledging that the patient is the single most important contributor to success in diabetes care, start-up companies have set out to make insulin delivery easier. With a focus on ease of use as a clinical advantage, start-ups are offering new insulin delivery devices for two distinct markets: the full-featured (but easy to use) insulin pump for Type 1 diabetes, and the disposable, simple insulin patch/infuser for Type 2.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • NiliMedix Ltd.
  • Senior Management
  • Contact Info
  • NiliMedix Ltd.
    Phone: (972)
    Matam Park
    Haifa,
    Israel
Advertisement
Advertisement
UsernamePublicRestriction

Register